dc.creatorRodriguez, Iván
dc.creatorMolina, Vivian
dc.creatorMás, Rosa
dc.creatorIllnait, José
dc.creatorOyarzábal, Ambar
dc.creatorMendoza, Sarahí
dc.creatorFernández, Lilia
dc.creatorFernández, Julio
dc.creatorGámez, Rafael
dc.creatorMesa, Meylis
dc.creatorJiménez, Sonia
dc.creatorBorrero, Lisete
dc.creatorCruz, Yadira
dc.creatorPérez, Yohani
dc.date2010
dc.date2010-11-10T03:00:00Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/8047
dc.identifierhttp://www.latamjpharm.org/resumenes/29/7/LAJOP_29_7_1_20.pdf
dc.descriptionD-004, a lipid extract of Roystonea regia fruits that prevents testosterone-induced prostate hyperplasia in rodents, and saw palmetto (SP) lipid extract, used to treat benign prostate hyperplasia, have been shown antioxidant effects. This randomized, double-blind study compared their antioxidant effects in forty healthy men randomised to D-004 or SP (320 mg/day) capsules for 8 weeks. D-004 significantly (p < 0.001) reduced plasma malondialdehyde (MDA) (32.7 %), sulphydril groups (SH-G) (24.6 %) and (p < 0.01) total hydroxyperoxides (TOH) (26.5 %) values and increased (p < 0.001) total antioxidant status (TAS) (44.1 %) and catalase (CAT) (100.0 %) activity. Treatment with SP lowered (p < 0.001) MDA (26.6 %), SH-G (24.1 %), (p < 0.01) TOH (26.3 %) values, and raised (p < 0.001) TAS (57.4 %) and (p < 0.01) CAT (85.7 %) activity. Both treatments were similarly effective and well tolerated. Concluding, D- 004 and SP (320 mg/day) for 8 weeks similarly reduced plasma lipid peroxidation (MDA, TOH) and protein oxidation (SH-G) markers, increased TAS and CAT activity and were well tolerated in healthy men.
dc.descriptionColegio de Farmacéuticos de la Provincia de Buenos Aires
dc.formatapplication/pdf
dc.format1185-1192
dc.languageen
dc.relationLatin American Journal of Pharmacy
dc.relationvol. 29, no. 7
dc.subjectFarmacia
dc.titleComparison of the antioxidant effects of lipid extracts of Roystonea regia (D-004) and saw palmetto on blood oxidative variables of healthy men
dc.typeArticulo
dc.typeArticulo


Este ítem pertenece a la siguiente institución